Apoptosis and apoptosis-related proteins (Fas, Fas ligand, Blc-2, p53) in lymphoid elements of human ovarian tumors

European Journal of Gynaecological Oncology

Volumn 21, Issue 1, 2000, Pages 53-57

  Ben Hur, H ^a   Gurevich, P ^a   Huszar, M ^a   Ben Arie, A ^a   Berman, V ^a   Tendler, Y ^b   Zinder, O ^b   Tchanishev, R ^a   Gershon, S ^c   Mor, G ^d   Zaltsman, Y ^e   Kohen, F ^e   Zusman, I ^c  

^a KAPLAN MEDICAL CENTER   (Israel)

^b RAMBAM MEDICAL CENTER   (Israel)

^c HEBREW UNIVERSITY OF JERUSALEM   (Israel)

^d YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^e WEIZMANN INSTITUTE OF SCIENCE   (Israel)

Author keywords

Apoptosis; bcl 2; Fas and Fas ligand; Lymphocytes; Ovarian epithelial tumors

Indexed keywords

CD20 ANTIGEN; CD4 ANTIGEN; CD8 ANTIGEN; FAS ANTIGEN; FAS LIGAND; INTERLEUKIN 2 RECEPTOR; PROTEIN BCL 2; PROTEIN P53;

APOPTOSIS; ARTICLE; BENIGN TUMOR; CANCER GRADING; CELL DENSITY; CLINICAL ARTICLE; EPITHELIUM CELL; FEMALE; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LYMPHOID TISSUE; OVARY TUMOR; PROTEIN EXPRESSION; T LYMPHOCYTE;

ADENOCARCINOMA; ANTIGENS, CD4; ANTIGENS, CD8; ANTIGENS, CD95; APOPTOSIS; DISEASE PROGRESSION; FEMALE; HUMANS; LIGANDS; LYMPHOCYTES, TUMOR-INFILTRATING; OVARIAN NEOPLASMS; PROTO-ONCOGENE PROTEINS C-BCL-2; TUMOR SUPPRESSOR PROTEIN P53;

EID: 17444447873     PISSN: 03922936     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (22)

1. Schroder W., Vering A., Stegmuller M., Strolmeier R.: "Lymphocyte subsets in patients with ovarian and breast cancer". Eur. J. Oncol., 1997, 18, 474.
2. Schondorf T., Engel H., Kurbacher C. M., Brenne U., Kolhagen H., Gobring U. J., Scharl A., Mallmann P.: "Immunologic features of tumor-infiltrating lymphocytes and peripheral blood lymphocytes in ovarian cancer patients". J. Soc. Gynecol. Invest., 1998, 5, 102.
3. Drozdzik M., Qian C., Lasarte J. J., Bilbao R., Prieto J.: ~"Antitumor effect of allogenic fibroblasts engineered to express Fas ligand (FasL)". Gene Therapy, 1998, 5, 1622.
4. Nagata S.: "Human autoimmune lymphoproliferative syndrome, a defect in the apoptosis-inducing Fas receptor: a lesson from the mouse model". H. Human Genet., 1998, 43, 2.
5. Ben-Hur H., Gurevich P., Huszar M., Berman V., Ben-Arie A., Tendler Y. et al.: "Expression of apoptosis and apoptosis-related proteins in human ovarian tumors of different histologic grades: immunohistochemical and morphometric studies". Eur. J. Gynaecol. Oncol., 1999, 20, 249.
6. Gurevich P., Czernobilsky B., Ben-Hur H., Nyska A., Zuckerman A., Zusman I.: "Pathology of lymphoid organs in low-birth weight human fetuses subjected to antigen-induced influences: a morphological and morphometric study". Pediatric Pathol., 1994, 14, 679.
7. Wong P. Y., Staren E. D., Tereshkova N., Braun D. P.: ~"Functional analysis of tumor-infiltrating leukocytes in breast cancer patients". J. Surg. Res., 1998, 76, 95.
8. McMillan D. C., Fyffe G. D., Wotherspoon H. A., Cooke T. G., Mcardle C. S.: "Prospective study of circulating T lymphocyte subpopulations and disease progression in colarectal cancer". Dis. Colon Rectum., 1997, 40, 1068.
9. Hartveit F.: "Breast cancer: poor short-term prognosis in cases with moderate lymphocyte infiltration at the tumour edge: a preliminary report". Oncol. Rep., 1998, 5, 423.
10. Stephens M., Lim K., Stephens P., Thomas D. W., Lim S. H.: "Molecular characterisation of tumour infiltrating lymphocytes in oral squamous cell carcinoma". Cancer Immun. Immunother., 1998, 46, 34.
11. Yannelli J. R., McConnell S., Parker L., Nishimura M., Robbins P., Yang J. et al.: "Melanoma tumor-infiltrating lymphocytes derived from four distinct anatomic sites obtained from a single patient: comparison of functional reactivity and melanoma antigen recognition". J. Immunother., 1995, 4, 263.
12. Naito Y., Saito K., Shiiba K., Ohuchi A., Saigenji K., Nagura A., Ohtani H.: "CD8+ T cells infiltrated within cancer cell nests as a prognostic factor in human colorectal cancer". Cancer Res., 1998, 58, 3491.
13. Grekou A. N., Toliou T., Stravoravdi P., Patakiouta F., Tsoukalas T., Pinakidis M., Keramidas G.: "Correlation of apoptosis with the distribution and composition of lymphocytic infiltrate in human breast carcinomas". Anticancer Res., 1996, 16, 3991.
14. Yang E., Korsmeyer S. J.: "Molecular thanalopsis: a discourse on the bcl-2 family and cell death". Blood, 1996, 88, 386.
15. Green D. R., Ware C. F.: "Fas-ligand: privilege and peril". Proc. Natl. Acad. Sci. USA. 1997, 94, 598.
16. Niehans G. A., Brunner T., Frizelle S. P., Liston J. C., Salerno C. T., Knapp D. J. et al.: "Human lung carcinomas express Fas ligand". Cancer Res., 1997, 57, 1007.
17. Abe M., Kitsuki H., Saruwatari S., Asoh H., Sakurada T., Kuwata H. et al.: "Cancer cells isolated from malignant pleural and peritoneal effusions inhibit phospholipase A2 activity in human polymorphonuclear leukocytes". Cancer Lett., 1997, 121, 155.
18. Mantovani G., Maccio A., Massa E., Lai P., Manca G., Mudu C. et al.: "Relationships between Fas expression, activation molecule CD25, and functional activity of tumor-associated lymphomonocytes from neoplastic effusions". Oncol. Rep., 1998, 6, 235.
19. O'Connell J., O'Sullivan G. C., Collins J. K.: "The Fas counterattack: Fas-mediated T cell killing by colon cancer cells expressing Fas ligand". J. Exp. Med., 1996, 184, 1075.
20. Hahna M., Rimoldi D., Schreter M., Romero P., Schreier M., French L. E. et al.: "Melanoma cell expression of Fas (Apo-1/CD95) ligand: implications for tumor immune escape". Science, 1996, 274, 1363.
21. O'Sullivan C., Lewis C.: "Tumour-associated leukocytes: friends or foes in breast carcinoma". J. Pathol., 1994, 172, 229.
22. Berke G.: "The binding and lysis of target cells by cytotoxic lymphocytes: molecular and cellular aspects". Annual Rev Immunol., 1994, 12, 735.